{
  "id": "6112e6a75e90e0f6",
  "title": "U . S . FDA Grants Ipsen IPN60340 ( ICT01 ) Breakthrough Therapy Designation in First Line Unfit Acute Myeloid Leukemia - Pharma / BioTech / Nutrition - IPSEN Group",
  "description": "20260114T023000Z",
  "content": "",
  "source": "newswiretoday.com",
  "source_url": "https://www.newswiretoday.com/news/185433/",
  "published_at": "20260114T023000Z",
  "fetched_at": "2026-01-15T00:21:56.842948+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://www.newswiretoday.com/news/185433/",
    "url_mobile": "",
    "title": "U . S . FDA Grants Ipsen IPN60340 ( ICT01 ) Breakthrough Therapy Designation in First Line Unfit Acute Myeloid Leukemia - Pharma / BioTech / Nutrition - IPSEN Group",
    "seendate": "20260114T023000Z",
    "socialimage": "",
    "domain": "newswiretoday.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}